GAVILYTE-N

POLYETHYLENE GLYCOL-3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE AND SODIUM BICARBONATE · Lupin Pharmaceuticals,Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for GAVILYTE-N, covering 2009-05-27 to 2023-06-23. Get the full timeline:

Most recent: FDA Approved: GAVILYTE-N — Supplemental Application (Lupin Pharmaceuticals,Inc.)